Oncology

Rochester, Minn.-based Mayo Clinic has entered into a multiyear partnership with U.K.-based company Oxford Nanopore to explore genetic predispositions to cancer.

New York City-based Memorial Sloan Kettering Cancer Center is partnering with AstraZeneca and Sophia Genetics to bring its proprietary liquid biopsy and solid tumor cancer tests to a global market, according to an Oct. 18 news release. 

Here are nine systems and organizations developing artificial intelligence models to find and treat cancer faster:

Julie Gralow, MD, was named Woman Oncologist of the Year by Women Leaders in Oncology.

U.S. News & World Report evaluated 899 hospitals across the country and ranked them for treating leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers.

Even though a majority of breast cancer cases are diagnosed without a lump that can be detected, less than half recognize other symptoms often associated with it, according to new research from the Ohio State University Comprehensive Cancer Center.

Mass General Brigham President and CEO Anne Klibanski, MD, shared a muted reaction to longtime affiliate Dana-Farber Cancer Institute's decision to partner with another Boston health system for cancer care in a recent op-ed with the Boston Globe. 

Results from a pilot study led by New York City-based Memorial Sloan Kettering Cancer Center suggest that a single blood test may be able to detect the presence of 50 different cancer types, according to an Oct. 13 news release. 

More than 1.9 million people are estimated to develop new cancer cases and more than 609,000 are estimated to die of cancer in 2023, according to estimates compiled by the American Cancer Society.

HCA Healthcare's Johnston-Willis Hospital in Richmond, Va., is the first in the nation to provide a new treatment for patients with brain metastases from lung cancer.